Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial-Reference-Cited by-同舟云学术

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

Published:2007-07 Issue:9583 Volume:370 Page:230-239
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Catovsky D,Richards S,Matutes E,Oscier D,Dyer MJS,Bezares RF,Pettitt AR,Hamblin T,Milligan DW,Child JA,Hamilton MS,Dearden CE,Smith AG,Bosanquet AG,Davis Z,Brito-Babapulle V,Else M,Wade R,Hillmen P

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials;J Natl Cancer Inst,1999

2. Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia;O'Brien;J Clin Oncol,2001

3. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia;Damle;Blood,1999

4. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia;Hamblin;Blood,1999

5. Genomic aberrations and survival in chronic lymphocytic leukemia;Dohner;N Engl J Med,2000

Cited by 634 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress on hCNT3 Structure/Function and Nucleoside Anticancer Drugs;Current Protein & Peptide Science;2024-02

2. Indolente (niedrig maligne) Non-Hodgkin-Lymphome;Facharztwissen Hamatologie Onkologie;2024

3. The Pathology according to p53 Pathway;Pathobiology;2023-11-14

4. Modern approach to the treatment of chronic lymphocytic leukemia;Onkologie;2023-10-05

5. Sex-specific differences of special tumor diseases;Die Innere Medizin;2023-07-17